Vertigo medical therapy: Difference between revisions

	Vertigo Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Vertigo from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Vertigo medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Vertigo medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Vertigo medical therapy
CDC on Vertigo medical therapy
Vertigo medical therapy in the news
Blogs on Vertigo medical therapy
Directions to Hospitals Treating Vertigo
Risk calculators and risk factors for Vertigo medical therapy

VisualWikitext

Revision as of 18:12, 28 December 2020

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Zehra Malik, M.B.B.S [2]


Treating Peripheral Vertigo
Ménière’s disease	Treatment is focused on preventing acute attacks and controlling the excess fluid build-up. Non-invasive: Low-sodium diet, hearing aid, positive pressure therapy. Medications: Meclizine, diazepam, promethazine, diuretics Steroid^[1] or gentamicin^[2] injections in middle ear. Surgery: Decompress endolymphatic sac, labyrinthectomy, Vestibular nerve section^[3].
Acoustic neuroma	Observe if the tumor is small, asymptomatic, not growing, or in elderly with comorbidities. For large, symptomatic, growing tumor one of the following treatment is helpful after weighing risks and benefits: Radiationtherapy Radiosurgery Surgical removal
Benign positional paroxysmal vertigo	Effective maneuvers:Epley maneuver, Semont maneuver, Brandt–Daroff exercises, Roll maneuver.^[4] Medical: Antihistamine(meclizine) and anticholinergic(scopolamine).^[5] Surgical: For resistant and severe cases occlusion of semi-circular canal may be helpful.
Acute labyrinthitis	Depends upon the etiology: Viral: hydration, bedrest.^[6] Bacterial: Antibiotic depending on the origin of infection that led to labyrinthitis.
Acute vestibular neuritis	Symptomatic:Antiemetic, antihistamine, benzodiazepines. These medicines should not be used for more than three days as the central compensation can get delayed leading to recurrent, chronic vertigo.^[7] Steroid efficacy is controversial. ^[8]
Cholesteatoma
Otosclerosis
Perilymphatic fistula
Treating Central Vertigo
Brainstem Stroke
Vestibular Migraine
Multiple Sclerosis
Cerebellar tumors
Lateral medullary syndrome

↑ Phillips, John S; Westerberg, Brian (2011). "Intratympanic steroids for Ménière's disease or syndrome". Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD008514.pub2. ISSN 1465-1858.
↑ Postema, Rolf J.; Kingma, Charlotte M.; Wit, Hero P.; Albers, Frans W.J.; Van Der Laan, Bernard F.A.M. (2009). "Intratympanic gentamicin therapy for control of vertigo in unilateral Menière's disease: a prospective, double-blind, randomized, placebo-controlled trial". Acta Oto-Laryngologica. 128 (8): 876–880. doi:10.1080/00016480701762458. ISSN 0001-6489.
↑ Syed, I.; Aldren, C. (2012). "Meniere's disease: an evidence based approach to assessment and management". International Journal of Clinical Practice. 66 (2): 166–170. doi:10.1111/j.1742-1241.2011.02842.x. ISSN 1368-5031.
↑ . doi:10.1002/14651858.CD003162. Check |doi= value (help). Missing or empty |title= (help)
↑ "Meclizine Hydrochloride Monograph for Professionals". American Society of Health-System Pharmacists. Retrieved 22 March 2019
↑ Seemungal, B M; Bronstein, A M (2008). "A practical approach to acute vertigo". Practical Neurology. 8 (4): 211–221. doi:10.1136/jnnp.2008.154799. ISSN 1474-7758.
↑ Muncie HL, Sirmans SM, James E (2017). "Dizziness: Approach to Evaluation and Management". Am Fam Physician. 95 (3): 154–162. PMID 28145669.
↑ Fishman, Jonathan M; Burgess, Chris; Waddell, Angus (2011). "Corticosteroids for the treatment of idiopathic acute vestibular dysfunction (vestibular neuritis)". Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD008607.pub2. ISSN 1465-1858.

[PhillipsWesterberg2011-1] Phillips, John S; Westerberg, Brian (2011). "Intratympanic steroids for Ménière's disease or syndrome". Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD008514.pub2. ISSN 1465-1858.

[PostemaKingma2009-2] Postema, Rolf J.; Kingma, Charlotte M.; Wit, Hero P.; Albers, Frans W.J.; Van Der Laan, Bernard F.A.M. (2009). "Intratympanic gentamicin therapy for control of vertigo in unilateral Menière's disease: a prospective, double-blind, randomized, placebo-controlled trial". Acta Oto-Laryngologica. 128 (8): 876–880. doi:10.1080/00016480701762458. ISSN 0001-6489.

[SyedAldren2012-3] Syed, I.; Aldren, C. (2012). "Meniere's disease: an evidence based approach to assessment and management". International Journal of Clinical Practice. 66 (2): 166–170. doi:10.1111/j.1742-1241.2011.02842.x. ISSN 1368-5031.

[4] . doi:10.1002/14651858.CD003162. Check |doi= value (help). Missing or empty |title= (help)

[5] "Meclizine Hydrochloride Monograph for Professionals". American Society of Health-System Pharmacists. Retrieved 22 March 2019

[SeemungalBronstein2008-6] Seemungal, B M; Bronstein, A M (2008). "A practical approach to acute vertigo". Practical Neurology. 8 (4): 211–221. doi:10.1136/jnnp.2008.154799. ISSN 1474-7758.

[pmid28145669-7] Muncie HL, Sirmans SM, James E (2017). "Dizziness: Approach to Evaluation and Management". Am Fam Physician. 95 (3): 154–162. PMID 28145669.

[FishmanBurgess2011-8] Fishman, Jonathan M; Burgess, Chris; Waddell, Angus (2011). "Corticosteroids for the treatment of idiopathic acute vestibular dysfunction (vestibular neuritis)". Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD008607.pub2. ISSN 1465-1858.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

@@ Line 38: / Line 38: @@
 ![[Acute vestibular neuritis]]
 |
-*
+*Symptomatic:[[Antiemetic]], [[antihistamine]], [[benzodiazepines]]. These [[medicines]] should not be used for more than three days as the central compensation can get delayed leading to recurrent, [[chronic]] vertigo.<ref name="pmid28145669">{{cite journal| author=Muncie HL, Sirmans SM, James E| title=Dizziness: Approach to Evaluation and Management. | journal=Am Fam Physician | year= 2017 | volume= 95 | issue= 3 | pages= 154-162 | pmid=28145669 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28145669  }} </ref>
+*[[Steroid]] efficacy is controversial. <ref name="FishmanBurgess2011">{{cite journal|last1=Fishman|first1=Jonathan M|last2=Burgess|first2=Chris|last3=Waddell|first3=Angus|title=Corticosteroids for the treatment of idiopathic acute vestibular dysfunction (vestibular neuritis)|journal=Cochrane Database of Systematic Reviews|year=2011|issn=14651858|doi=10.1002/14651858.CD008607.pub2}}</ref>
 |-
 ![[Cholesteatoma]]

Vertigo medical therapy: Difference between revisions

Revision as of 18:12, 28 December 2020

Navigation menu